Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT06512129
Recruiting Observational

Defining Volume Status in Sepsis With Extracellular Water Measurement

NCT06512129 · tracked via the Priya Life Science Sweden tracker
Sponsor
Uppsala University
Phase
Observational
Started
2025-03-01
Last updated
2026-01-14

Condition(s) studied

Sepsis

Study summary

The goal of this observational study is to learn about the influence of extracellular water on volume status in adult sepsis patients presenting with hemodynamic instability. The main question it aims to answer is:

• Can measurement of extracellular water (MoistureMeterD, Delfin Technologies Ltd, Kuopio, Finland) contribute to the description of hemodynamic instability in adult sepsis patients.

Patients with sepsis admitted to intensive care will receive standard care with the addition of measurement of extracellular water.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults with sepsis. Exclusion Criteria: * Pregnancy, other than sepsis known cause of shock.

Primary outcome measure(s)

  • Phenotypes in sepsis - extracellular water for volume status characterization. — 7 days
    Can measurement of extracellular water (MoistureMeterD, Delfin Technologies Ltd, Kuopio, Finland) contribute to the description of hemodynamic instability in adult sepsis patients during the first 72 hours?

Trial sites (1)

FacilityCityRegionStatus
AnOpIva Uppsala Uppsa Recruiting

More Uppsala University trials in Sweden

Efficacy of Hyperthermic Intraperitoneal Chemotherapy Recruiting
Robotic-Assisted Pedicle Screw Placement in Spine Surgery Recruiting
The Scandinavian Displaced Lateral Clavicle Trial Recruiting
Fusion or Not - a Study on Low Back Pain Recruiting
Nutrition and Inflammation in Patients With Head and Neck Cancer Active, not recruiting

Other trials for the same condition

Human Milk Fortification in Extremely Preterm Infants Active, not recruiting
Swecrit Biobank - Blood Samples From Critically Ill Patients and Healthy Controls Active, not recruiting
Bacteremia From Periodontal Treatment to Elucidate the Underpinnings of Sepsis Active, not recruiting
Establishment of Reference Limits for Blood Lactate Levels in Intensive Care Patients With a Particular Focus on Age and Sex Active, not recruiting
Inflammatory Mediators of Acute Kidney Injury in Intensive Care Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06512129 on ClinicalTrials.gov ↗ ← All trials in Sweden